Oligonucleotides specific for hepatitis c virus

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) C12Q 1/70 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2226438

The present invention discloses synthetic oligonucleotides complementary to contiguous and non-contiguous regions of the HCV RNA. Also disclosed are methods and kits for inhibiting the replication of HCV, inhibiting the expression of HCV nucleic acid and protein, and for treating HCV infections.

On décrit des oligonucléotides synthétiques complémentaires de régions contigües et non contigües de l'ARN du virus de l'hépatite C (VHC), de même que des procédés et des trousses permettant d'inhiber la réplication du VHC, d'inhiber l'expression de l'acide nucléique et des protéines du VHC, et de traiter les infections dues au VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oligonucleotides specific for hepatitis c virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotides specific for hepatitis c virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides specific for hepatitis c virus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1519833

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.